Cargando…

Age‐specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross‐sectional study

BACKGROUND: Primary human papillomavirus (HPV) screening is recommended for the detection of cervical intraepithelial neoplasia (CIN) in the general population; however, the triage for HPV‐positive women remains a challenge. This study aimed to evaluate the age‐specific effectiveness of primary HPV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bao, Heling, Ma, Lan, Zhao, Yanxia, Song, Bo, Di, Jiangli, Wang, Linhong, Gao, Yanqiu, Ren, Wenhui, Wang, Shi, Wu, Jiuling, Wang, Hai‐Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923126/ https://www.ncbi.nlm.nih.gov/pubmed/35142100 http://dx.doi.org/10.1002/cac2.12256

Ejemplares similares

Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study
por: Zhao, Yanxia, et al.
Publicado: (2021)

Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
por: van Rosmalen, J, et al.
Publicado: (2012)

Evaluation of cytology versus human papillomavirus-based cervical cancer screening algorithms in Bhutan
por: Tshomo, Ugyen, et al.
Publicado: (2017)

Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan
por: Sasaki, Yuri, et al.
Publicado: (2017)

Cost-effectiveness of artificial intelligence-assisted liquid-based cytology testing for cervical cancer screening in China
por: Shen, Mingwang, et al.
Publicado: (2023)

A nationally quasi-experimental study to assess the impact of partial organized breast and cervical cancer screening programme on participation and inequalities
por: Bao, Heling, et al.
Publicado: (2020)

The artificial intelligence‐assisted cytology diagnostic system in large‐scale cervical cancer screening: A population‐based cohort study of 0.7 million women
por: Bao, Heling, et al.
Publicado: (2020)

Repeat Cytology and Human Papillomavirus Screening Strategies in Detecting Preinvasive Cervical Lesions
por: Li, Kemin, et al.
Publicado: (2015)

Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment
por: Stuebs, Frederik A., et al.
Publicado: (2022)

Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs
por: Kantathavorn, Nuttavut, et al.
Publicado: (2015)

Knowledge of Cervical Cancer Screening among Women across Different Socio-Economic Regions of China
por: Di, Jiangli, et al.
Publicado: (2015)

Cervical Cancer Screening Coverage — China, 2018–2019
por: Zhang, Mei, et al.
Publicado: (2022)

Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above
por: Rebolj, Matejka, et al.
Publicado: (2016)

Genotype distribution and prevalence of human papillomavirus among women with cervical cytological abnormalities in Xinjiang, China
por: Wang, Jing, et al.
Publicado: (2019)

Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology
por: Zehbe, Ingeborg, et al.
Publicado: (2016)

Clinical Performance of Human Papillomavirus (HPV) Testing versus Cytology for Cervical Cancer Screening: Results of a Large Danish Implementation Study
por: Thomsen, Louise T, et al.
Publicado: (2020)

An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme
por: Sherlaw-Johnson, C, et al.
Publicado: (2004)

The Application of Liquid-Based Cytological Detection for P16, Cytologic Evaluation and High-Risk Human Papillomavirus Testing in Cervical Cancer Screening: A Clinical Evaluation
por: Zhao, Fang, et al.
Publicado: (2022)

How Can a High-Performance Screening Strategy Be Determined for Cervical Cancer Prevention? Evidence From a Hierarchical Clustering Analysis of a Multicentric Clinical Study
por: Bao, Heling, et al.
Publicado: (2022)

Prevalence of High-Risk Human Papillomavirus in Cervical Intraepithelial Neoplasia in the Pre-Vaccine Era — China, 2017–2018
por: Bao, Heling, et al.
Publicado: (2022)

Error Rates in Cervical Cytological Screening Tests
por: May, D.
Publicado: (1974)

Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer
por: Kailash, U, et al.
Publicado: (2006)

Utilization of Human Papillomavirus DNA Detection for Cervical Cancer Screening in Women Presenting With Abnormal Cytology in Lokoja, Nigeria
por: Kolawole, Olatunji, et al.
Publicado: (2015)

16/18 genotyping in triage of persistent human papillomavirus infections with negative cytology in the English cervical screening pilot
por: Rebolj, Matejka, et al.
Publicado: (2019)

Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile
por: Brebi, Priscilla, et al.
Publicado: (2017)

Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model
por: de Kok, Inge M C M, et al.
Publicado: (2012)

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
por: Dillner, Joakim, et al.
Publicado: (2008)

Cytological DNA methylation for cervical cancer screening: a validation set
por: Kong, Linghua, et al.
Publicado: (2023)

Human papillomavirus testing in cervical cancer screening
por: Franceschi, S, et al.
Publicado: (2005)

Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs
por: Gupta, Sarah, et al.
Publicado: (2018)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

HPV-genotyping versus conventional cervical cytology as a screening method to detect dysplastic cervical epithelial changes
por: Abbas, Mahmoud, et al.
Publicado: (2022)

Significant variations in the cervical cancer screening rate in China by individual‐level and geographical measures of socioeconomic status: a multilevel model analysis of a nationally representative survey dataset
por: Bao, Heling, et al.
Publicado: (2018)

Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines
por: Demarco, Maria, et al.
Publicado: (2017)

Cervical Cancer Screening in South Florida Veteran Population, 2014 to 2020: Cytology and High-Risk Human Papillomavirus Correlation and Epidemiology
por: Syler, Lee B, et al.
Publicado: (2021)

Prevalence and risk factors for cervical neoplasia: a cervical cancer screening program in Beijing
por: Tao, Lixin, et al.
Publicado: (2014)

Human papillomavirus ‘reflex’ testing as a screening method in cases of minor cytological abnormalities
por: Fröberg, M, et al.
Publicado: (2008)

Breast Cancer Screening Coverage — China, 2018–2019
por: Zhang, Mei, et al.
Publicado: (2023)

Cervical Human Papillomavirus Screening among Older Women
por: Grainge, Matthew J., et al.
Publicado: (2005)

Cervical cancer case–control audit: Results from routine evaluation of a nationwide cervical screening program
por: Wang, Jiangrong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oicjiqh0o26cqcamumlmb7rjj3